Massalia Therapeutics
PrivateLast Round
Grant
Oct 14, 2025
Total Funding Raised
$650,000
Company Overview
Massalia Therapeutics is a biotechnology company that develops therapeutic platforms for the treatment of complex conditions intersecting oncology, fibrosis, and neovascularization.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Massalia Therapeutics Comparables
Compare Massalia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kekkan Biologics | 76% | |
| SPIMA Therapeutics | 75% | |
| Elikya Therapeutics | 70% | |
Massalia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 14, 2025 | ||||
| Seed | May 19, 2025 |
Massalia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SATT Sud-Est | Seed |
| Landmark BioVentures AG | Seed |
| Bpifrance | Grant |
Massalia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Massalia Therapeutics's valuation, stock price, and market status.